In a busy week that includes much-anticipated quarterly reports, a pair of standouts among the finance and aerospace sectors ...

President Trump announced on Truth Social that Coca-Cola “has agreed” to replace high-fructose corn syrup with real cane ...

Alphabet GOOGL and Apple AAPL are the two most well-known providers of consumer apps marketplaces through Google Pay Store ...

With presence in more than 190 countries worldwide, NKE leverages its iconic branding, innovation-led product development and ...

Indian retail investors ramped up US stock purchases amid global market volatility, with a strong tilt toward semiconductors, ...

HIMS benefits from strong online revenue, subscriber growth, and global expansion moves to fuel its health platform momentum. However, challenges may hurt performance.

RTX Corp. RTX is slated to release second-quarter 2025 results on July 22, before the opening bell.

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the ...

Digging Into the Bargain Bin Investing in beaten-down stocks can be a savvy strategy for long-term wealth creation, as it ...

Hims & Hers Health partnered with Novo Nordisk earlier this year, only for that to unravel shortly afterward due to ...

Hims & Hers (HIMS) stock in focus as the company faces a growing number of lawsuits following Novo Nordisk's (NVO) decision ...

Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...